Company Filing History:
Years Active: 2002-2005
Title: The Innovations of Dexiang Chen
Introduction
Dexiang Chen is a notable inventor based in Madison, Wisconsin. He has made significant contributions to the field of biotechnology, particularly in the development of vaccine compositions. With a total of two patents to his name, Chen's work has the potential to impact public health positively.
Latest Patents
One of Chen's latest patents involves the isolation and purification of a 74-kilodalton outer membrane protein from Moraxella catarrhalis. This protein, designated as the 74 kD protein, has an amino-terminal amino acid sequence that is conserved among various strains. The protein has a molecular weight of approximately 74.9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is utilized to prepare a vaccine composition that elicits a protective immune response in a mammalian host, aimed at protecting against diseases caused by this specific protein.
Career Highlights
Throughout his career, Dexiang Chen has worked with prominent companies in the biotechnology sector. Notably, he has been associated with American Cyanamid Company and Wyeth Holdings Corporation. His experience in these organizations has contributed to his expertise in the field.
Collaborations
Chen has collaborated with several professionals in his field, including Karl R. VanDerMeid and John C. McMichael. These collaborations have likely enriched his research and development efforts.
Conclusion
Dexiang Chen's innovative work in the field of biotechnology, particularly with the 74-kilodalton outer membrane protein, showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in vaccine development and public health.